AD 15
Alternative Names: AD-15Latest Information Update: 08 Sep 2023
At a glance
- Originator ADvantage Therapeutics
- Class Antidementias
- Mechanism of Action Klotho protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Alzheimer's disease
Most Recent Events
- 08 Sep 2023 Early research in Alzheimer's disease in USA (unspecified route) (ADvantage Therapeutics pipeline, September 2023)